PhD J. Mattsson MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Isolated limb perfusion with tumor necrosis factor alpha and melphalan (TM-ILP) has proven to be a successful option in treating advanced soft tissue sarcomas (STS), where amputation otherwise is needed to achieve safe surgical margins. From 2000 to 2009, 54 patients with locally advanced STS, who all were candidates for amputation, were treated with(More)
  • 1